Clinical experience doxazosin general medical practice New Zealand study safety efficacy doxazosin treatment large population patients essential hypertension effect doxazosin serum lipid profile calculated risk coronary heart disease Patients groups baseline diastolic blood pressure equal mm Hg group baseline diastolic blood pressure mm Hg group previous antihypertensive therapy Doxazosin treatment monotherapy patients blood pressure patients group mm Hg weeks control blood pressure patients group Heart rate unchanged groups Mean final daily doses mg groups Treatment doxazosin severity category hypertension patients group patients therapy success Doxazosin favorable effect serum lipid profile groups patients majority lipid changes statistical significance significant decrease calculated risk coronary heart disease Doxazosin patients side effects treatment patients dose doxazosin patients doxazosin therapy side effects 